Want to see JAZZ full AI Analyst Report?
Jazz Pharmaceuticals (JAZZ) Revenue
Jazz Pharmaceuticals Revenue
Jazz Pharmaceuticals had a revenue of 1.21B in the quarter ending Jun 30, 2026, with 13.04%. This bring the company's revenue in the last twelve months to 4.60B, Increased 3.66%. In the fiscal year ending Dec 31, 2025, Jazz Pharmaceuticals had annual revenue of 4.27B with 4.88% growth.
- Revenue (ttm)
- 4.60B
- Revenue Growth
- 12.59%
- P/S Ratio
- 3.29
- Revenue/Employee
- $1,476,673
- Employees
- 2,890
- Market Cap
- $14.02B
Revenue Chart
Jazz Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.27B | 198.64M | 4.88% |
| Dec 31, 2024 | 4.07B | 234.75M | 6.12% |
| Dec 31, 2023 | 3.83B | 174.83M | 4.78% |
| Dec 31, 2022 | 3.66B | 565.14M | 18.26% |
| Dec 31, 2021 | 3.09B | 730.67M | 30.91% |
| Dec 31, 2020 | 2.36B | 201.81M | 9.34% |
| Dec 31, 2019 | 2.16B | 270.84M | 14.32% |
| Dec 31, 2018 | 1.89B | 272.23M | 16.82% |
| Dec 31, 2017 | 1.62B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.